Skip to main content
. 2019 Dec;8(8):2680–2690. doi: 10.21037/tcr.2019.10.27

Table 5. Association of prechemotherapy CA199, CA72.4 with response to chemotherapy.

Tumor marker N Response [n (%)] P value
Clinical benefit Non-clinical benefit
CA199 0.016
   ≥80 U/mL 26 24 (92.3) 2 (7.7)
   <80 U/mL 54 37 (68.5) 17 (31.5)
CA72.4 0.003
   ≥20 U/mL 35 32 (91.4) 3 (8.6)
   <20 U/mL 40 25 (62.5) 15 (37.5)